Epilepsy affects an estimated ten million people in China, making it one of the country's most prevalent neurological conditions, yet the diagnostic workup and treatment optimization for epilepsy patients across much of China remains inadequate relative to international standards, with limited EEG monitoring capacity, inadequate access to advanced neuroimaging for epileptogenic lesion...